Immunotherapy alone extended life for metastatic lung cancer patients with KRAS mutation

(University of Pennsylvania School of Medicine) Real-word evidence is suggesting, for the first time, the most beneficial treatment courses that could help extend the lives of patients with metastatic non-small cell lung cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news